We are live on ! Find out more
MAKO

MAKO SURGICAL CORP COM
MAKO

Delisted

MAKO was delisted on the 16th of December, 2013.

144 hedge funds and large institutions have $1.01B invested in MAKO SURGICAL CORP COM in 2013 Q3 according to their latest regulatory filings, with 47 funds opening new positions, 42 increasing their positions, 36 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

196% more capital invested

Capital invested by funds: $340M → $1.01B (+$665M)

133% more call options, than puts

Call options by funds: $96.1M | Put options by funds: $41.3M

57% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 30

17% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 36

13% more funds holding

Funds holding: 128144 (+16)

Holders
144
Holders Change
+16
Holders Change %
+12.5%
% of All Funds
4.67%
Holding in Top 10
9
Holding in Top 10 Change
+9
Holding in Top 10 Change %
% of All Funds
0.29%
New
47
Increased
42
Reduced
36
Closed
30
Calls
$96.1M
Puts
$41.3M
Net Calls
+$54.8M
Net Calls Change
+$66M
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
26
Stevens Capital Management
Pennsylvania
$9.93M +$5.13M +336,519 New
MF
27
Magnetar Financial
Illinois
$9.88M +$5.1M +334,628 New
TC
28
TFS Capital
Pennsylvania
$8.73M -$3.7M -242,663 -45%
Norges Bank
29
Norges Bank
Norway
$8.3M +$2.29M +150,121 +115%
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$8.06M +$297K +19,520 +8%
VAM
31
Visium Asset Management
New York
$7.8M -$2M -131,137 -33%
AGA
32
Altrinsic Global Advisors
Connecticut
$6.49M
JG
33
Jefferies Group
New York
$6.39M +$3.3M +216,717 New
Bank of New York Mellon
34
Bank of New York Mellon
New York
$6.27M -$300K -19,711 -8%
Geode Capital Management
35
Geode Capital Management
Massachusetts
$5.93M +$466K +30,590 +18%
BIA
36
Biondo Investment Advisors
Pennsylvania
$5.65M +$164K +10,770 +6%
GCP
37
GSA Capital Partners
United Kingdom
$5.56M +$2.87M +188,328 New
TCIM
38
TIAA CREF Investment Management
New York
$5.39M +$21.3K +1,399 +0.8%
Capstone Investment Advisors
39
Capstone Investment Advisors
New York
$5.16M +$2.67M +175,000 New
Axa
40
Axa
France
$5.15M +$9.2K +604 +0.3%
EIP
41
Epoch Investment Partners
New York
$5M -$85.3K -5,600 -3%
CS
42
Credit Suisse
Switzerland
$4.2M +$1.74M +114,400 +411%
Alyeska Investment Group
43
Alyeska Investment Group
Illinois
$3.94M +$2.03M +133,414 New
Deutsche Bank
44
Deutsche Bank
Germany
$3.84M -$4.13M -271,300 -68%
Jane Street
45
Jane Street
New York
$3.6M +$1.33M +86,991 +248%
BIM
46
BlackRock Investment Management
Delaware
$3.49M +$110K +7,231 +7%
PP
47
Paloma Partners
Connecticut
$3.39M +$1.75M +115,000 New
Nomura Holdings
48
Nomura Holdings
Japan
$3.39M +$1.47M +96,637 +530%
STC
49
SEI Trust Company
Pennsylvania
$3.38M -$422K -27,700 -19%
WAM
50
Wolverine Asset Management
Illinois
$3.38M +$1.75M +114,600 New

MAKO Hedge Fund Activity: Q3 2013 in Review

144 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in MAKO SURGICAL CORP COM (MAKO) for Q3 2013, worth a combined $1.01B — up 196% from $340M a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new MAKO positions and 30 closed out — a net gain of 17 holders — while 42 added to existing stakes and 36 trimmed.

The largest buyer was Oxford Asset Management, opening a new position worth an estimated $59.2M. The largest seller was OrbiMed, exiting entirely with an estimated $26.7M sold.

  • 144 institutional investors held MAKO SURGICAL CORP COM (MAKO) as of Q3 2013, up from 128 in Q2 2013.
  • Funds reported $1.01B of MAKO SURGICAL CORP COM stock for Q3 2013, up 196% quarter-over-quarter.
  • 47 funds opened new MAKO SURGICAL CORP COM positions in Q3 2013 and 30 closed out, a net change of +17 holders.
  • The largest MAKO SURGICAL CORP COM buyer in Q3 2013 was Oxford Asset Management, an estimated $59.2M added.
  • The largest MAKO SURGICAL CORP COM seller in Q3 2013 was OrbiMed, an estimated $26.7M sold.

Based on aggregated 13F filings for Q3 2013.